DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 8,304,196 B2 Caprioli (45) Date of Patent: *Nov

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 8,304,196 B2 Caprioli (45) Date of Patent: *Nov USOO83 041.96B2 (12) United States Patent (10) Patent No.: US 8,304,196 B2 Caprioli (45) Date of Patent: *Nov. 6, 2012 (54) INSITUANALYSIS OF TISSUES 6,809,315 B2 10/2004 Ellson et al. .................. 250/288 7,534.338 B2 5/2009 Hafeman et al. ... 205/288 O O 2003.0049701 A1* 3, 2003 Muraca .......... 435/723 (75) Inventor: Richard Caprioli, Brentwood, TN (US) 2003/0186287 A1 10, 2003 Lin et al. 435/6 2004.0007673 A1* 1 2004 Coon et al. .. 250,424 (73) Assignee: Vanderbilt University, Nashville, TN 2007/0082356 A1 4/2007 Strom et al. ...................... 435/6 (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this WO WOO1,26460 4/2001 patent is extended or adjusted under 35 WO WOO3,O34024 4/2003 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS This patent is Subject to a terminal dis- Schwartz et al. (J. Mass Spectrometry 2003 vol. 38, p. 699-708).* claimer. Pauletti et al. (J. Clin. Oncology 2000 vol. 18, 3651-3664).* Office Action issued in U.S. Appl. No. 1 1/355.912, mailed Apr. 3, (21) Appl. No.: 12/942,840 2008. Office Action issued in U.S. Appl. No. 1 1/355.912, mailed Dec. 8, 1-1. 2009. (22) Filed: Nov. 9, 2010 Office Action issued in U.S. Appl. No. 1 1/355.912, mailed May 22, O O 2009. (65) Prior Publication Data Yanagisawa et al., “Proteomic patterns of tumour Subsets in non US 2011 FO190145 A1 Aug. 4, 2011 Small-cell lung cancer.” The Lancet, 362:433-439, 2003. Related U.S. Application Data * c1tedcited bby examiner (63) Continuation of application No. 1 1/355,912, filed on Primary Examiner — Jacob Cheu Feb. 16, 2006, now Pat. No. 7,829,291. (74) Attorney, Agent, or Firm — Parker Highlander PLLC (60) sal application No. 60/653,665, filed on Feb. (57) ABSTRACT s The present invention provides for the simultaneous assess (51) Int. Cl. ment of a plurality of tissue regions or microregions, the GOIN33/53 (2006.01) benefit being homogeneity of the sampling, both in terms of (52) U.S. Cl. ......................................... 435/7.1436/518 tissue content and timing. Discrete regions of a tissue sample, (58) Field of Classification Search s None such as those demarcated by microwells formed within the See application file for complete search history tissue itself or tissue plugs removed from the tissue in a spatially referenced fashion, can be treated with one or more (56) References Cited physical or chemical treatments to liberate target molecules of interest. Subsequent analysis of said target molecules by, U.S. PATENT DOCUMENTS e.g., mass spectroscopy, permits identification of a variety of biological parameters, including those associated with dis 4,932,412 A 6/1990 Goldenberg .................. 600,431 5,384,260 A * 1/1995 Osborne et al. .. ... 436/64 ease or therapy. 6,677,503 B1 1/2004 Bidney et al. ... 800,279 6,707,038 B2 3/2004 Ellson et al. .................. 250/288 8 Claims, 20 Drawing Sheets U.S. Patent Nov. 6, 2012 Sheet 1 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 2 of 20 US 8,304,196 B2 : U.S. Patent Nov. 6, 2012 Sheet 3 of 20 US 8,304,196 B2 s U.S. Patent Nov. 6, 2012 Sheet 4 of 20 US 8,304,196 B2 r Y U.S. Patent Nov. 6, 2012 Sheet 5 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 6 of 20 US 8,304,196 B2 ? U.S. Patent Nov. 6, 2012 Sheet 7 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 8 of 20 US 8,304,196 B2 &#8 U.S. Patent Nov. 6, 2012 Sheet 9 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 10 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 11 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 12 of 20 US 8,304,196 B2 i 9886/a GZO/92 o SN CC'972 LOCGdz isS. k- N sc 60.18 v B s (f) 98008 68'06/ke CD : CD 68'0A 2n s (5s GA629 eas s 71,097 CO "689 CO A72 2 d '86 ke 98.1 99.80 gig 190 a 3 sk Se N vv Li-6 E 67'998 9792. SSA cr'84 verg ---,-,-,-,-,-,-,-,-, -, -8 3 s. s is is a s is is se o' U.S. Patent Nov. 6, 2012 Sheet 13 of 20 US 8,304,196 B2 b2(+1), FM(+1)- 28 296.8 LHFFMPGFAPLTSR 100 251,0399 296.8 y5(+1), MPGFAP(+1)-28 y9(+1), FMPGFAPLT(+1)- 18 1104.309 1580.1340 70,0855 20 KE2 1452.0557 60 10 d13a, 577.1033 50 398,0202 oil. Availabilitial. WAAA E. E. 69.0 397.2 725.4 1053.6 1381.8 1710.0 40 3.0781 85,0494 361.0090 5730519 945.2168 9.0709 644.0821 28.2119 1104.3091 1580.1340 395.0302.0238 21 545.041 76.0421 862 31.4859 1308.4983 1505A.' O 3.01796, 854B553 392 e 69.0 397.2 725.4 1053.6 1381.8 1710.0 FIG. 11B U.S. Patent Nov. 6, 2012 Sheet 14 of 20 US 8,304,196 B2 100 L. 90 0.0677 YTVAAIFR 542.9 80 1(+1) 86.0976 70 10070, 60 542.9 90 50 V7 an 40 80 175,1194 by b2(+1) b3b3(1) - 18(+1) 70 20 A +1) 60 10 838 b6(+1) 897.2039 1010.6800 O : E. EEAA s s 50 72.083 69.0 277.6 486.2 694.8 903.4 1112.0 40 120,0935 30 B4O675 59,1082 29,0943 78.2990 20 15.0947 77.2423 10 B i3.1384,720,2926T 619.7313 B97.2039 1010.680 O O P. t y dolski a E.R.AEAlish kill, 69.0 277.6 4862 6948 903.4 1112.0 FIG. 11C U.S. Patent Nov. 6, 2012 Sheet 16 of 20 US 8,304,196 B2 HRDTGILDSGR 1586.5 110.1055 100. b11 + H2O(+1) 1586.5 90 40 112.1.194 y1 (+1),DS(+1) - 28 y9(+1) 8O 86.1396 ye1) y9 - 17(+1) y10(+1)11(1) 1299. 432 70 7O 1126 situal SA4. M91) 295.353 60 69 338 6O7 876 1145 1414 50 1183.9572 40 112.1194 908.54O2 30 175.1152 1204 20 129.1276.277.1223432.2048 931,6248 1299.5432 10 4620 6412934 8104.5" 165.8959 549.2264 1291.4321 69 338 607 876 1145 1414 F.G. 12B U.S. Patent Nov. 6, 2012 Sheet 17 of 20 US 8,304,196 B2 FG 13 U.S. Patent US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 19 of 20 US 8,304,196 B2 U.S. Patent Nov. 6, 2012 Sheet 20 of 20 US 8,304,196 B2 S. US 8,304,196 B2 1. 2 INSITU ANALYSIS OF TISSUES comprising (a) providing an intact tissue comprising a first spatially discrete microregion; (b) Subjecting the microregion This application is a Continuation Application of U.S. to one or more physical or chemical treatments; and (c) ana patent application Ser. No. 1 1/355,912 filed Feb. 16, 2006, lyzing a protein sample from the microregion, thereby pro now U.S. Pat. No. 7,829,291 which claims benefit of priority to U.S. Provisional Application Ser. No. 60/653,665, filed viding analysis of protein content in the tissue. The intact Feb. 17, 2005, the entire contents of both applications are tissue may further comprise at least a second spatially dis hereby incorporated by reference in their entirety. crete microregion, and the method further comprises Subject ing the second spatially discrete microregion to one or more BACKGROUND OF THE INVENTION physical or chemical treatments, and analyzing discrete a 10 protein sample from the second spatially discrete microre 1. Field of the Invention gion, and the protein content of the first and second spatially The present invention relates generally to the fields of discrete microregions may be compared. Protein encom molecular biology. More particularly, it concerns measure passes both peptides and polypeptides. One or more of the ment of biological molecules in situ in a tissue sample. Spe steps may be automated. cifically, the invention provides for creation of a series of 15 microwells in a single tissue or tissue region, thereby permit The provision of a microregion may involve different ting analysis of proteins, nucleic acids, lipids, carbohydrates, aspects. In one embodiment, the microregion may comprise a drugs and other biomolecules in a homogeneous set of reac well in a larger tissue section. The well may be a true depres tions. sion or hole in the tissue, or a channel structure created in the 2. Description of Related Art tissue. Multiple wells, depressions or holes can be created in With the completion of the Human Genome Project, a spatially distinct manner. Alternatively, the intact tissue may emphasis is shifting to examining the protein complement of be extracted from a larger tissue section, i.e., a tissue plug. the human organism. This has given rise to the Science of The plug may then be transferred to a support for further proteomics, the study of all the proteins produced by cell type treatment and analysis, and may be placed adjacent to other and organism.
Load more

Recommended publications
  • Peraturan Badan Pengawas Obat Dan Makanan Nomor 28 Tahun 2019 Tentang Bahan Penolong Dalam Pengolahan Pangan
    BADAN PENGAWAS OBAT DAN MAKANAN REPUBLIK INDONESIA PERATURAN BADAN PENGAWAS OBAT DAN MAKANAN NOMOR 28 TAHUN 2019 TENTANG BAHAN PENOLONG DALAM PENGOLAHAN PANGAN DENGAN RAHMAT TUHAN YANG MAHA ESA KEPALA BADAN PENGAWAS OBAT DAN MAKANAN, Menimbang : a. bahwa masyarakat perlu dilindungi dari penggunaan bahan penolong yang tidak memenuhi persyaratan kesehatan; b. bahwa pengaturan terhadap Bahan Penolong dalam Peraturan Kepala Badan Pengawas Obat dan Makanan Nomor 10 Tahun 2016 tentang Penggunaan Bahan Penolong Golongan Enzim dan Golongan Penjerap Enzim dalam Pengolahan Pangan dan Peraturan Kepala Badan Pengawas Obat dan Makanan Nomor 7 Tahun 2015 tentang Penggunaan Amonium Sulfat sebagai Bahan Penolong dalam Proses Pengolahan Nata de Coco sudah tidak sesuai dengan kebutuhan hukum serta perkembangan ilmu pengetahuan dan teknologi sehingga perlu diganti; c. bahwa berdasarkan pertimbangan sebagaimana dimaksud dalam huruf a dan huruf b, perlu menetapkan Peraturan Badan Pengawas Obat dan Makanan tentang Bahan Penolong dalam Pengolahan Pangan; -2- Mengingat : 1. Undang-Undang Nomor 18 Tahun 2012 tentang Pangan (Lembaran Negara Republik Indonesia Tahun 2012 Nomor 227, Tambahan Lembaran Negara Republik Indonesia Nomor 5360); 2. Peraturan Pemerintah Nomor 28 Tahun 2004 tentang Keamanan, Mutu dan Gizi Pangan (Lembaran Negara Republik Indonesia Tahun 2004 Nomor 107, Tambahan Lembaran Negara Republik Indonesia Nomor 4424); 3. Peraturan Presiden Nomor 80 Tahun 2017 tentang Badan Pengawas Obat dan Makanan (Lembaran Negara Republik Indonesia Tahun 2017 Nomor 180); 4. Peraturan Badan Pengawas Obat dan Makanan Nomor 12 Tahun 2018 tentang Organisasi dan Tata Kerja Unit Pelaksana Teknis di Lingkungan Badan Pengawas Obat dan Makanan (Berita Negara Republik Indonesia Tahun 2018 Nomor 784); MEMUTUSKAN: Menetapkan : PERATURAN BADAN PENGAWAS OBAT DAN MAKANAN TENTANG BAHAN PENOLONG DALAM PENGOLAHAN PANGAN.
    [Show full text]
  • Medical Bacteriology
    LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology.
    [Show full text]
  • Xerox University Microfilms
    INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1.The sign or "target" for pages apparently lacking from the document photographed is "Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image. You will find a good image of the page in the adjacent frame. 3. When a map, drawing or chart, etc., was part of the material being photographed the photographer followed a definite method in "sectioning" the material. It is customary to begin photoing at the upper left hand corner of a large sheet and to continue photoing from left to right in equal sections with a small overlap. If necessary, sectioning is continued again — beginning below the first row and continuing on until complete. 4. The majority of users indicate that the textual content is of greatest value, however, a somewhat higher quality reproduction could be made from "photographs" if essential to the understanding of the dissertation.
    [Show full text]
  • Course Title: Systemic Bacteriology & Mycology
    COURSE TITLE: BACTERIOLOGY COURSE CODE: MIPA-219 RECOMMENDED BOOKS 1. Essentials of Veterinary Microbiology (Fifth Edition) By G. R. Carter, M. M. Chengappa and C. A. W. Roberts 2. Veterinary Bacteriology and Virology By I. A .Merchant and R. A. Packer 3. Text Book of Veterinary Microbiology By S. N. Sharma and S. C. Adlakha 4. Pathogenesis of Bacterial Infections in Animals By C. L. Gyles and C. O. Thoen 5. Veterinary Microbiology and Microbial disease By P. J. Quinn, B. K. Markey, M. E. Carter, W. J. C. Donnelly, F. C. Leonard 6. Topley and Wilson‟s Microbiology and Microbial Infections (Volume-3; 9th Edition) By L. Collier, A. Balows and M.Sussman For Practical Class Purposes 1. Diagnostic Procedures in Veterinary Bacteriology and Mycology By G. R. Carter and J. R. Cole, Jr. 2. Color Atlas and Textbook of Diagnostic Microbiology (Fifth Edition) By Elmer W. Koneman et.al 1 BACTERIAL CLASSIFICATION AND NOMENCLATURE Systematic Bacteriology Systematic Bacteriology is a branch of Microbiology which embraces the classification and nomenclature of bacteria. Taxonomy Taxonomy is defined as the science of classification (orderly arrangement of organisms). Nomenclature Nomenclature is naming an organism by international rules according to its characteristics. Identification Identification refers - i. To isolate and distinguish desirable organisms from undesirable ones. ii. To verify the authenticity or special properties of a culture. Isolate An isolate is a pure culture derived from a heterogenous, wild population of microorganisms. Classification Classification can be defined as the arrangement of organisms into taxonomic groups (taxa) on the basis of similarities or relationships. Biochemical, physiologic, genetic and morphologic properties are often necessary for an adequate description of a taxon.
    [Show full text]
  • Manual D'estil Per a Les Ciències De Laboratori Clínic
    MANUAL D’ESTIL PER A LES CIÈNCIES DE LABORATORI CLÍNIC Segona edició Preparada per: XAVIER FUENTES I ARDERIU JAUME MIRÓ I BALAGUÉ JOAN NICOLAU I COSTA Barcelona, 14 d’octubre de 2011 1 Índex Pròleg Introducció 1 Criteris generals de redacció 1.1 Llenguatge no discriminatori per raó de sexe 1.2 Llenguatge no discriminatori per raó de titulació o d’àmbit professional 1.3 Llenguatge no discriminatori per raó d'ètnia 2 Criteris gramaticals 2.1 Criteris sintàctics 2.1.1 Les conjuncions 2.2 Criteris morfològics 2.2.1 Els articles 2.2.2 Els pronoms 2.2.3 Els noms comuns 2.2.4 Els noms propis 2.2.4.1 Els antropònims 2.2.4.2 Els noms de les espècies biològiques 2.2.4.3 Els topònims 2.2.4.4 Les marques registrades i els noms comercials 2.2.5 Els adjectius 2.2.6 El nombre 2.2.7 El gènere 2.2.8 Els verbs 2.2.8.1 Les formes perifràstiques 2.2.8.2 L’ús dels infinitius ser i ésser 2.2.8.3 Els verbs fer, realitzar i efectuar 2.2.8.4 Les formes i l’ús del gerundi 2.2.8.5 L'ús del verb haver 2.2.8.6 Els verbs haver i caldre 2.2.8.7 La forma es i se davant dels verbs 2.2.9 Els adverbis 2.2.10 Les locucions 2.2.11 Les preposicions 2.2.12 Els prefixos 2.2.13 Els sufixos 2.2.14 Els signes de puntuació i altres signes ortogràfics auxiliars 2.2.14.1 La coma 2.2.14.2 El punt i coma 2.2.14.3 El punt 2.2.14.4 Els dos punts 2.2.14.5 Els punts suspensius 2.2.14.6 El guionet 2.2.14.7 El guió 2.2.14.8 El punt i guió 2.2.14.9 L’apòstrof 2.2.14.10 L’interrogant 2 2.2.14.11 L’exclamació 2.2.14.12 Les cometes 2.2.14.13 Els parèntesis 2.2.14.14 Els claudàtors 2.2.14.15
    [Show full text]
  • "The Mode of Action of Bacillus Thuringiensis (Berliner) Against The
    b"ç'aB r: The UniversitY of Adelaide Faculty of Agricultural and Natural Resource Sciences "The mode of action of Bacillus thuringiensis (Berliner) against the sheep lous e, Bovicolø ovis (Schrank)." by CATITERINE ALEXANDRA HILL Department of Crop Protection WAITE CAMPUS Glen Osmond, South Australia Thesis submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy. January, 1998. Frontispiece. Adult sheep biting lice, Bovicola ovis (Schrank) in the sheep fleece. SUMMARY Bacillus thuringiensrs, (Bt) produces a heterogeneous range of insecticidal toxins, the most notable being the ð-endotoxin crystal proteins effective against lepidopteran, dipteran and coleopteran larvae. Dulmage (1981) reported that certain strains of Bt produced an uncharacterised "louse factor" effective against phthirapteran species. Bt strain WB3S16, isolated from sheep fleece at the University of Adelaide, Waite Campus, causes very high mortality when ingested by the sheep biting louse B. ovis. This strain is currently being developed as a microbial insecticide for control of B. ovis. The objective of this study was to determine the nature and mode of action of the Bt strain \ryB3sl6 louse toxin effective against B. ovis. Bt fed B. ovis exhibit midgut disruption and histopathological effects which are similar to those of the ð-endotoxin crystal proteins in susceptible lepidopteran and coleopteran larvae (Hill and Pinnock, 1997). Investigations were made in this study to determine whether the Bt strain WB3S16 louse toxin is related or identical to the ð-endotoxin crystal proteins produced by this bacterium. A louse toxic factor was found in association with the Bt strain WB3S16 membranes and the culture supernatant following growth of the bacterium.
    [Show full text]
  • Biofiles V5 N5
    Biofiles Volume 5, Number 5 Enzymes and Reagents for Alternative Energy Metabolic strategies in alternative energy Enzyme-based fuel cells Lignocellulosic depolymerization Enzymes for biofuel research Reagents for ethanol and biodiesel analysis Biofilesonline Biofilescontents Your gateway to Biochemicals and Reagents for Life Science Research Introduction 3 BioFiles Online allows you to: Advancements in Enzyme-Based • Easily navigate the content of Fuel Cell Batteries, Sensors and the current BioFiles issue Emissions Reduction Strategies 8 • Access any issue of BioFiles • Subscribe for email notifications Selected Enzymes for Biofuel of future eBioFiles issues Cell Research 10 Register today for upcoming issues and eBioFiles announcements at Enzymes and Reagents for sigma.com/biofiles Ethanol Research 12 Enzymes for Lignocellulosic Greener Products Ethanol Research 12 Sigma-Aldrich is committed to doing our Enzymes for Starch Hydrolysis 20 part to minimize our footprint on the Ethanol Analysis 23 environment. As a life science and high technology company, we recognize your Enzymes for BioDiesel Research 24 need for high quality chemicals comes Lipase 24 first. In cases where it becomes possible to consider alternatives, we have made it Phospholipase C 24 easier for you to find greener options BioDiesel Analysis 25 through our new “Greener Alternatives and Technologies” product lists. Metabolic Standards for Mevalonate and Isoprenoid Pathway Analysis 30 Products Including: • Quality Environmentally-Friendly Enzymes • Ionic Liquids • Greener Alternatives: Solvents • Greener Alternatives: Reagents sigma-aldrich.com/green Life Science Labware Center The Life Science Labware Center allows easy browsing of labware products, including disposables, books, and equipment Features Include: • Corning® cell culture selection guide • Products by top manufacturers • New products by research areas • New lab start-up programs Start using the Life Science Labware center at sigma-aldrich.com/lslabware Technical content: Robert Gates, M.
    [Show full text]
  • Self Assessment & Review: Microbiology & Immunology, 4Th
    Self Assessment & Review MMUNOLOGY Self Assessment & Review MMUNOLOGY 4th Edition Rachna Chaurasia MD Radiodiagnosis MLB Medical College, Jhansi, India Anshul Jain MD Anaesthesia MLB Medical College, Jhansi, India the arora medical book publishers pvt. ltd. A Group of Jaypee Brothers Medical Publishers (P) Ltd. Published by Jitendar P Vij Jaypee Brothers Medical Publishers (P) Ltd Corporate Office 4838/24 Ansari Road, Daryaganj, New Delhi - 110002, India, Phone: +91-11-43574357 Registered Office B-3 EMCA House, 23/23B Ansari Road, Daryaganj, New Delhi - 110 002, India Phones: +91-11-23272143, +91-11-23272703, +91-11-23282021, +91-11-23245672 Rel: +91-11-32558559, Fax: +91-11-23276490, +91-11-23245683 e-mail: [email protected], Website: www.jaypeebrothers.com Branches ❑ 2/B, Akruti Society, Jodhpur Gam Road Satellite Ahmedabad 380 015, Phones: +91-79-26926233, Rel: +91-79-32988717 Fax: +91-79-26927094, e-mail: [email protected] ❑ 202 Batavia Chambers, 8 Kumara Krupa Road, Kumara Park East Bengaluru 560 001, Phones: +91-80-22285971, +91-80-22382956 91-80-22372664, Rel: +91-80-32714073, Fax: +91-80-22281761 e-mail: [email protected] ❑ 282 IIIrd Floor, Khaleel Shirazi Estate, Fountain Plaza, Pantheon Road Chennai 600 008, Phones: +91-44-28193265, +91-44-28194897 Rel: +91-44-32972089, Fax: +91-44-28193231, e-mail: [email protected] ❑ 4-2-1067/1-3, 1st Floor, Balaji Building, Ramkote Cross Road, Hyderabad 500 095, Phones: +91-40-66610020, +91-40-24758498 Rel:+91-40-32940929Fax:+91-40-24758499, e-mail: [email protected]
    [Show full text]
  • POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii
    POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii http://rcin.org.pl WSKAZÓWKI DLA AUTORÓW Kwartalnik „Postępy Biochemii” publikuje artykuły monograficzne omawiające wąskie tematy, oraz artykuły przeglądowe referujące szersze zagadnienia z biochemii i nauk pokrewnych. Artykuły pierwszego typu winny w sposób syntetyczny omawiać wybrany temat na podstawie możliwie pełnego piśmiennictwa z kilku ostatnich lat, a artykuły drugiego typu na podstawie piśmiennictwa z ostatnich dwu lat. Objętość takich artykułów nie powinna przekraczać 25 stron maszynopisu (nie licząc ilustracji i piśmiennictwa). Kwartalnik publikuje także artykuły typu minireviews, do 10 stron maszynopisu, z dziedziny zainteresowań autora, opracowane na podstawie najnow­ szego piśmiennictwa, wystarczającego dla zilustrowania problemu. Ponadto kwartalnik publikuje krótkie noty, do 5 stron maszynopisu, informujące o nowych, interesujących osiągnięciach biochemii i nauk pokrewnych, oraz noty przybliżające historię badań w zakresie różnych dziedzin biochemii. Przekazanie artykułu do Redakcji jest równoznaczne z oświadczeniem, że nadesłana praca nie była i nie będzie publikowana w innym czasopiśmie, jeżeli zostanie ogłoszona w „Postępach Biochemii”. Autorzy artykułu odpowiadają za prawidłowość i ścisłość podanych informacji. Autorów obowiązuje korekta autorska. Koszty zmian tekstu w korekcie (poza poprawieniem błędów drukarskich) ponoszą autorzy. Artykuły honoruje się według obowiązujących stawek. Autorzy otrzymują bezpłatnie 25 odbitek swego artykułu; zamówienia na dodatkowe odbitki (płatne) należy zgłosić pisemnie odsyłając pracę po korekcie autorskiej. Redakcja prosi autorów o przestrzeganie następujących wskazówek: Forma maszynopisu: maszynopis pracy i wszelkie załączniki należy nadsyłać w dwu egzem­ plarzach. Maszynopis powinien być napisany jednostronnie, z podwójną interlinią, z marginesem ok. 4 cm po lewej i ok. 1 cm po prawej stronie; nie może zawierać więcej niż 60 znaków w jednym wierszu nie więcej niż 30 wierszy na stronie zgodnie z Normą Polską.
    [Show full text]
  • Monophosphate Phosphodiesterase Activity from Rat Brain by A
    Proc. ANat. Acad. Sci. USA Vol. 70, No. 12, Part I, pp. 3526-3530, December 1973 Regulation of Nucleoside Cyclic 3': 5 '-Monophosphate Phosphodiesterase Activity from Rat Brain by a Modulator and Ca2+ (rat cerebral cortex/Ca2+plus Mg2+-dependent phosphodiesterase/cyclic AMP/ cyclic GMP/modulator protein) SHIRO KAKIUCHI, REIKO YAIAZAKI, YOSHIKO TESHIMA, AND KUNIHIRO UENISHI The Research Division and Clinical Laboratory, Nakamiya Mental Hospital, Hirakata, Osaka, Japan Communicated by Lewis Thomas, August 8, 1973 ABSTRACT Gel filtration of the 40,000 rpm super- isolated free of phosphodiesterase activity, effectively recon- natant fraction of a homogenate of rat cerebral cortex on a stituted the activity of the purified enzyme. This activator Sepharose 6B column yielded two fractions: fraction II with the "Cal+ plus Mg'+-dependent" phosphodiesterase was found to be heat stable (1). A similar activator was also activity and fraction III containing its modulator. The found in heart muscle (1, 4) and, more recently, it has been activity of fraction II was stimulated by micromolar purified to apparent homogeneity (9). The mechanism and concentrations of Cal+ and the modulator when present physiological significance of the regulation of phosphodies- together; the modulator stimulated the activity of fraction II only when the Ca2+ concentration was above a threshold terase activity by this activator are unclear. A recent report value (about 2 uM with 0.4-1 MM substrate), and the stimu- by Wang and his coworkers (6) indicated that cAMP slowly latoryr efrect of Ca2+ was dependent upon the presence of activated heart phosphodiesterase, possibly by enhancing the the modulator. A possibility is discussed that the modu- interaction between the enzyme and the activator.
    [Show full text]
  • Protein Synthesis in Neuronal Perikarya Isolated from Cerebral Cortex of the Imma- Ture Rat1
    Journal of Neurochemistry, 1972, Vol. 19, pp. 699 to 711. Pergamon Press. Printed in Great Britain. PROTEIN SYNTHESIS IN NEURONAL PERIKARYA ISOLATED FROM CEREBRAL CORTEX OF THE IMMA- TURE RAT1 H. H. KOHLand 0. Z. SELLINGER~ Mental Health Research Institute, The University of Michigan Medical Centre, Ann Arbor, Michigan 48104. (Receiued 9 August 1971. Accepted 8 October 1971) Abstract-Homogenates of neuronal perikarya isolated from the cerebral cortex of the 8-day-old rat were incubated with [3H]leucine, and the characteristics of the protein syn- thetic process were studied. Incorporation of leucine into protein was linear up to 90 min, proceeded optimally at pH 7.6 and was stimulated by K+ and NH4+, unaffected by Li+ and inhibited by Na+. Puromycin, cycloheximide, RNAse, sulphhydryl blocking agents and phospholipase A exerted a pronounced inhibition, whereas chloramphenicol and phos- pholipase C had no effect. About 42 per cent of the total radioactive protein formed in the optimally fortified in uitro system was recovered in non-sedimentable form. Tncorpor- ationinto the subcellular fractions of the neuronal perikarya increased steadily with increasing time of incubation. The microsomal fraction acquired the highest specific radioactivity (d.p.m./mg of protein), followed by the mitochondria1 and the nuclear + cell debris fractions. The high-speed soluble fraction exhibited the lowest specific radioactivity. Although the addition of L-methionineto a suitably fortified incubation medium inhibited neuronal protein synthesis by about 80
    [Show full text]
  • Biochemistry Higher Secondary - Second Year
    BIOCHEMISTRY HIGHER SECONDARY - SECOND YEAR Untouchability is a sin Untouchability is a crime Untouchability is inhuman TAMIL NADU TEXT BOOK CORPORATION College Road, Chennai - 600 006 © Government of Tamilnadu First Edition - 2005 Chairperson Dr.D. Sakthisekaran Professor of Biochemistry, University of Madras, Taramani Campus, Chennai - 600 113 Reviewers Dr.P. Samudram Dr.(Mrs.) C.S. Shyamala Devi Asst.Prof. of Biochemistry (Retd.) Prof. and Head (Retd.) Institute of Biochemistry Dept.of Biochemistry Madras Medical College University of Madras Chennai - 600 003 Guindy Campus, Chennai -25 Dr.(Mrs.) P. Varalakshmi Professor & Head, Dept. of Medical Biochemistry University of Madras, Taramani Campus, Chennai - 600 113 Authors Dr.(Mrs.) A.Geetha Thiru. P.N. Venkatesan Reader in Biochemistry P.G.Assistant Bharathi Women’s College Govt. Higher Secondary School Chennai - 600 108. Paradarami, Vellore - 632 603 Dr.(Mrs.) R. Sheela Devi Dr. S. Subramanian Lecturer , Dept. of Physiology Lecturer, Dept. of Biochemistry University of Madras University of Madras Taramani Campus, Chennai -113. Guindy Campus, Chennai - 25. Dr. (Mrs.) P. Kalaiselvi Lecturer, Dept. of Medical Biochemistry University of Madras, Taramani Campus, Chennai - 600 113 Price : Rs. This book has been prepared by the Directorate of School Education on behalf of the Government of Tamilnadu This book has been printed on 60 GSM Paper Printed by Offset at: CONTENTS Page 1. Cell Memberane 1 2. Digestion 27 3. Carbohydrate Metabolism 43 4. Protein Metabolism 73 5. Lipid Metabolism 101 6. Nucleic acid Metabolism 121 7. Inborn Errors of Metabolism 143 8. Biological Oxidation 157 9. Enzyme Kinetics 179 10. Immunology 199 11. Practicals 233 CHAPTER I Cell Membrane Introduction The outer living boundary of the cell is called as the cell membrane or ‘Plasma membrane’.
    [Show full text]